Filtros de búsqueda

Lista de obras de

A Phase I trial of protracted oral fixed-dose temozolomide

artículo científico publicado en 2005

A Phase II Trial of Dose-Dense Neoadjuvant Gemcitabine, Epirubicin, and Albumin-Bound Paclitaxel With Pegfilgrastim in the Treatment of Patients With Locally Advanced Breast Cancer ⬇️

artículo científico publicado el 1 de octubre de 2010

A Phase II Trial of Oxaliplatin and Trastuzumab in the Treatment of HER2-Positive Metastatic Breast Cancer ⬇️

artículo científico publicado el 1 de octubre de 2010

A Phase II Trial of Vinflunine As Monotherapy or in Combination with Trastuzumab as First-Line Treatment of Metastatic Breast Cancer ⬇️

artículo científico publicado el 1 de noviembre de 2010

A Phase II trial of Denileukin Diftitox in patients with previously treated advanced non-small cell lung cancer.

artículo científico publicado en 2009

A Phase II, Open-Label, Randomized Study to Assess the Efficacy and Safety of AZD6244 (ARRY-142886) Versus Pemetrexed in Patients with Non-small Cell Lung Cancer Who Have Failed One or Two Prior Chemotherapeutic Regimens ⬇️

artículo científico publicado el 1 de octubre de 2010

A Randomized Phase II Study of Paclitaxel and Bevacizumab With and Without Gemcitabine as First-Line Treatment for Metastatic Breast Cancer ⬇️

artículo científico publicado el 1 de julio de 2011

A Randomized Phase II Trial of Pemetrexed/Gemcitabine/Bevacizumab or Pemetrexed/Carboplatin/Bevacizumab in the First-Line Treatment of Elderly Patients with Advanced Non-small Cell Lung Cancer ⬇️

artículo científico publicado el 1 de enero de 2012

A Randomized, Open-Label Phase 2 Study of the CXCR4 Inhibitor LY2510924 in Combination with Sunitinib Versus Sunitinib Alone in Patients with Metastatic Renal Cell Carcinoma (RCC).

artículo científico

A Retrospective Study of Treatment Outcomes in Patients With Carcinoma of Unknown Primary Site and a Colorectal Cancer Molecular Profile ⬇️

artículo científico publicado el 14 de octubre de 2011

A phase 2 study of the sphingosine-1-phosphate antibody sonepcizumab in patients with metastatic renal cell carcinoma

artículo científico publicado en 2016

A phase I trial of weekly paclitaxel plus prolonged oral eniluracil/5-fluorouracil in patients with refractory malignancies

artículo científico publicado en 2002

A phase I/II study of exisulind in combination with docetaxel/carboplatin in patients with metastatic non-small-cell lung cancer

artículo científico publicado en 2005

A phase II feasibility trial of dose-dense docetaxel followed by doxorubicin/cyclophosphamide as adjuvant or neoadjuvant treatment for women with node-positive or high-risk node-negative breast cancer

artículo científico publicado en 2008

A phase II randomized crossover study of liposomal doxorubicin versus weekly docetaxel in the first-line treatment of women with metastatic breast cancer

artículo científico publicado en 2009

A phase II study of higher dose weekly topotecan in relapsed small-cell lung cancer

artículo científico publicado en 2011

A phase II study of two dose levels of ofatumumab induction followed by maintenance therapy in symptomatic, previously untreated chronic lymphocytic leukemia

artículo científico publicado en 2016

A phase II trial of bevacizumab and everolimus as treatment for patients with refractory, progressive intracranial meningioma

artículo científico publicado en 2016

A phase II trial of carboplatin and weekly topotecan in the first-line treatment of patients with extensive stage small cell lung cancer.

artículo científico publicado en 2010

A phase II trial of gemcitabine/carboplatin with or without trastuzumab in the first-line treatment of patients with metastatic breast cancer

artículo científico publicado en 2008

A phase II trial of ixabepilone and cyclophosphamide as neoadjuvant therapy for patients with HER2-negative breast cancer: correlation of pathologic complete response with the 21-gene recurrence score

artículo científico publicado en 2015

A phase II trial of neoadjuvant gemcitabine, epirubicin, and docetaxel as primary treatment of patients with locally advanced or inflammatory breast cancer

artículo científico publicado en 2010

A pilot study of adjuvant nanoparticle albumin-bound (nab) paclitaxel and cyclophosphamide, with trastuzumab in HER2-positive patients, in the treatment of early-stage breast cancer

artículo científico publicado en 2010

A randomised non-comparative phase II trial of cixutumumab (IMC-A12) or ramucirumab (IMC-1121B) plus mitoxantrone and prednisone in men with metastatic docetaxel-pretreated castration-resistant prostate cancer

artículo científico publicado en 2015

A review of phase II studies of ZD9331 treatment for relapsed or refractory solid tumours ⬇️

artículo científico publicado el 1 de mayo de 2003

A single-arm, open-label, expanded access study of vemurafenib in patients with metastatic melanoma in the United States

artículo científico publicado en 2014

A systems pathology model for predicting overall survival in patients with refractory, advanced non-small-cell lung cancer treated with gefitinib

artículo científico publicado en 2009

ATLAS: randomized, double-blind, placebo-controlled, phase IIIB trial comparing bevacizumab therapy with or without erlotinib, after completion of chemotherapy, with bevacizumab for first-line treatment of advanced non-small-cell lung cancer.

artículo científico publicado en 2013

Adjuvant docetaxel for node-positive breast cancer

artículo científico publicado en 2005

Amrubicin and carboplatin with pegfilgrastim in patients with extensive stage small cell lung cancer: A phase II trial of the Sarah Cannon Oncology Research Consortium

artículo científico publicado en 2018

Amrubicin as second- or third-line treatment for women with metastatic HER2-negative breast cancer: a Sarah Cannon Research Institute phase 1/2 trial

artículo científico publicado en 2014

BRIDGE: An Open-Label Phase II Trial Evaluating the Safety of Bevacizumab + Carboplatin/Paclitaxel as First-Line Treatment for Patients with Advanced, Previously Untreated, Squamous Non-small Cell Lung Cancer ⬇️

artículo científico publicado el 1 de enero de 2011

Bevacizumab and everolimus in the treatment of patients with metastatic melanoma: a phase 2 trial of the Sarah Cannon Oncology Research Consortium

artículo científico publicado en 2010

Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer

artículo científico publicado en 2005

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

artículo científico publicado en 2004

Biomarker analyses from a randomized, placebo-controlled, phase IIIb trial comparing bevacizumab with or without erlotinib as maintenance therapy for the treatment of advanced non-small-cell lung cancer (ATLAS).

artículo científico publicado en 2014

Brief-duration rituximab/chemotherapy followed by maintenance rituximab in patients with diffuse large B-cell lymphoma who are poor candidates for R-CHOP chemotherapy: a phase II trial of the Sarah Cannon Oncology Research Consortium

artículo científico publicado en 2010

Cabazitaxel Plus Lapatinib as Therapy for HER2+ Metastatic Breast Cancer With Intracranial Metastases: Results of a Dose-finding Study

artículo científico publicado en 2018

Cancer of unknown primary site

artículo científico publicado en 2010

Carcinoma of unknown primary site: sequential treatment with paclitaxel/carboplatin/etoposide and gemcitabine/irinotecan: a Minnie Pearl Cancer Research Network phase II trial

artículo científico publicado en 2004

Circulating Tumor Cells in a Phase 3 Study of Docetaxel and Prednisone with or without Lenalidomide in Metastatic Castration-resistant Prostate Cancer

artículo científico publicado en 2016

Combination Chemotherapy with Gemcitabine and Vinorelbine in the Treatment of Patients with Relapsed or Refractory Small Cell Lung Cancer: A Phase II Trial of the Minnie Pearl Cancer Research Network ⬇️

artículo científico publicado el 1 de abril de 2003

Combination Treatment with Weekly Docetaxel and Gemcitabine for Advanced Non–Small-Cell Lung Cancer in Elderly Patients and Patients with Poor Performance Status: Results of a Minnie Pearl Cancer Research Network Phase II Trial ⬇️

artículo científico publicado el 1 de julio de 2003

Combination chemotherapy with gemcitabine and irinotecan in patients with previously treated carcinoma of an unknown primary site: a Minnie Pearl Cancer Research Network Phase II trial

artículo científico publicado en 2005

Combination therapy with fludarabine and rituximab followed by alemtuzumab in the first-line treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma: a phase 2 trial of the Minnie Pearl Cancer Research Network

artículo científico publicado en 2008

Concurrent radiotherapy and temozolomide followed by temozolomide and sorafenib in the first-line treatment of patients with glioblastoma multiforme

artículo científico publicado en 2010

Diagnosis, staging, and clinical characteristics of the patient with mediastinal germ cell carcinoma

artículo científico publicado en 2002

Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study

artículo científico publicado en 2015

Efficacy of bevacizumab plus erlotinib versus erlotinib alone in advanced non-small-cell lung cancer after failure of standard first-line chemotherapy (BeTa): a double-blind, placebo-controlled, phase 3 trial ⬇️

artículo científico publicado el 28 de mayo de 2011

Efficacy of octreotide long-acting repeatable in neuroendocrine tumors: RADIANT-2 placebo arm post hoc analysis

artículo científico publicado en 2015

Emerging Role of Topotecan in First-Line Therapy of Small-Cell Lung Cancer ⬇️

artículo científico publicado el 1 de marzo de 2003

Erlotinib plus either pazopanib or placebo in patients with previously treated advanced non-small cell lung cancer: A randomized, placebo-controlled phase 2 trial with correlated serum proteomic signatures

artículo científico publicado en 2018

Everolimus in combination with paclitaxel and carboplatin in patients with metastatic melanoma: a phase II trial of the Sarah Cannon Research Institute Oncology Research Consortium

artículo científico publicado en 2013

Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study

artículo científico publicado en 2011

Evolving understanding and management of poorly differentiated neuroendocrine tumors

artículo científico publicado en 2013

Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegib

artículo científico publicado en 2013

Final survival and safety results from a multicenter, open-label, phase 3b trial of erlotinib in patients with advanced nonsmall cell lung cancer

artículo científico publicado en 2008

First-Line Carboplatin, Pemetrexed, and Panitumumab in Patients with Advanced Non-Squamous KRAS Wild Type (WT) Non-Small-Cell Lung Cancer (NSCLC).

artículo científico publicado en 2017

First-line and maintenance treatment with rituximab for patients with indolent non-Hodgkin's lymphoma

artículo científico publicado en 2003

First-line treatment with brief-duration chemotherapy plus rituximab in elderly patients with intermediate-grade non-Hodgkin's lymphoma: phase II trial

artículo científico publicado en 2003

Follicular lymphoma in the United States: first report of the national LymphoCare study

scientific article published on 09 February 2009

Gefitinib in the Treatment of Advanced, Refractory Non–Small-Cell Lung Cancer: Results in 124 Patients ⬇️

artículo científico publicado el 1 de mayo de 2003

Gemcitabine, carboplatin, and paclitaxel for patients with carcinoma of unknown primary site: a Minnie Pearl Cancer Research Network study

artículo científico publicado en 2002

Gene expression profiling in patients with carcinoma of unknown primary site: from translational research to standard of care

artículo científico

Hematologic response to three alternative dosing schedules of azacitidine in patients with myelodysplastic syndromes

artículo científico publicado en 2009

High-Dose Bevacizumab in the Treatment of Patients With Advanced Clear Cell Renal Carcinoma: A Phase II Trial of the Sarah Cannon Oncology Research Consortium ⬇️

artículo científico publicado el 15 de mayo de 2013

High-dose etoposide: from phase I to a component of curative therapy

scientific article published on 06 October 2008

Hormonal Therapy Plus Bevacizumab in Postmenopausal Patients Who Have Hormone Receptor–Positive Metastatic Breast Cancer: A Phase II Trial of the Sarah Cannon Oncology Research Consortium ⬇️

artículo científico publicado el 20 de abril de 2011

Impact of bone-targeted therapies in chemotherapy-naïve metastatic castration-resistant prostate cancer patients treated with abiraterone acetate: post hoc analysis of study COU-AA-302.

artículo científico publicado en 2015

Induction paclitaxel, carboplatin, and infusional 5-FU followed by concurrent radiation therapy and weekly paclitaxel/carboplatin in the treatment of locally advanced head and neck cancer: a phase II trial of the Minnie Pearl Cancer Research Network

artículo científico publicado en 2002

Irinotecan plus gemcitabine induces both radiographic and CA 19-9 tumor marker responses in patients with previously untreated advanced pancreatic cancer

artículo científico publicado en 2002

Irinotecan, carboplatin, and imatinib in untreated extensive-stage small-cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network

artículo científico publicado en 2007

Lenalidomide in combination with gemcitabine as first-line treatment for patients with metastatic carcinoma of the pancreas: A Sarah Cannon Research Institute phase II trial ⬇️

artículo científico publicado el 28 de enero de 2013

Long-term follow-up of patients treated with paclitaxel/carboplatin-based chemotherapy for advanced non-small-cell lung cancer: sequential phase II trials of the Minnie Pearl Cancer Research Network

artículo científico publicado en 2002

Lung Adenocarcinoma with Anaplastic Lymphoma Kinase (ALK) Rearrangement Presenting as Carcinoma of Unknown Primary Site: Recognition and Treatment Implications

artículo científico publicado en 2016

Meeting the chemotherapy needs of elderly and poor performance status patients with NSCLC.

artículo científico publicado en 2002

Molecular Gene Expression Profiling to Predict the Tissue of Origin and Direct Site-Specific Therapy in Patients With Carcinoma of Unknown Primary Site: A Prospective Trial of the Sarah Cannon Research Institute ⬇️

artículo científico publicado el 10 de enero de 2013

Molecular Profiling Diagnosis in Unknown Primary Cancer: Accuracy and Ability to Complement Standard Pathology ⬇️

artículo científico publicado el 2 de mayo de 2013

Molecular profiling in unknown primary cancer: accuracy of tissue of origin prediction

artículo científico publicado en 2010

Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluation.

artículo científico publicado en 2008

Neoadjuvant Ixabepilone/Carboplatin/Trastuzumab in HER2-Positive Operable Breast Cancer: A Phase II Trial of the Sarah Cannon Research Institute

artículo científico publicado en 2014

Neoadjuvant chemotherapy/gefitinib followed by concurrent chemotherapy/radiation therapy/gefitinib for patients with locally advanced squamous carcinoma of the head and neck

artículo científico publicado en 2009

Neuroendocrine carcinoma of unknown primary site

artículo científico publicado en 2009

Oxaliplatin and capecitabine in the treatment of patients with recurrent or refractory carcinoma of unknown primary site: a phase 2 trial of the Sarah Cannon Oncology Research Consortium

artículo científico publicado en 2010

Paclitaxel and mitoxantrone in the treatment of metastatic breast cancer: a phase II trial of the Minnie Pearl Cancer Research Network

artículo científico publicado en 2002

Paclitaxel, bevacizumab, and everolimus/placebo as first-line treatment for patients with metastatic HER2-negative breast cancer: a randomized placebo-controlled phase II trial of the Sarah Cannon Research Institute

artículo científico publicado en 2015

Paclitaxel, carboplatin, and gemcitabine in the treatment of patients with advanced transitional cell carcinoma of the urothelium

artículo científico publicado en 2005

Paclitaxel, carboplatin, and oral etoposide as initial treatment for advanced ovarian carcinoma: a Minnie Pearl Cancer Research Network phase II trial

artículo científico publicado en 2005

Paclitaxel, carboplatin, and topotecan in the treatment of patients with small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network

artículo científico publicado en 2002

Paclitaxel/Carboplatin/gemcitabine versus gemcitabine/vinorelbine in advanced non-small-cell lung cancer: a phase II/III study of the Minnie Pearl Cancer Research Network

artículo científico publicado en 2007

Paclitaxel/carboplatin plus bevacizumab/erlotinib in the first-line treatment of patients with carcinoma of unknown primary site

artículo científico publicado en 2009

Paclitaxel/carboplatin with or without belinostat as empiric first-line treatment for patients with carcinoma of unknown primary site: A randomized, phase 2 trial

artículo científico publicado en 2015

Paclitaxel/carboplatin with or without sorafenib in the first-line treatment of patients with stage III/IV epithelial ovarian cancer: a randomized phase II study of the Sarah Cannon Research Institute

artículo científico publicado en 2014

Paclitaxel/carboplatin/etoposide versus gemcitabine/irinotecan in the first-line treatment of patients with carcinoma of unknown primary site: a randomized, phase III Sarah Cannon Oncology Research Consortium Trial

artículo científico publicado en 2010

Paclitaxel/carboplatin/etoposide versus paclitaxel/topotecan for extensive-stage small cell lung cancer: a Minnie Pearl Cancer Research Network randomized, prospective phase II trial

artículo científico publicado en 2005

Panitumumab, Gemcitabine, and Carboplatin as Treatment for Women With Metastatic Triple-Negative Breast Cancer: A Sarah Cannon Research Institute Phase II Trial

artículo científico publicado en 2016

Pazopanib and liposomal doxorubicin in the treatment of patients with relapsed/refractory epithelial ovarian cancer: a phase Ib study of the Sarah Cannon Research Institute

artículo científico publicado en 2015

Pazopanib as Second-Line Treatment After Sunitinib or Bevacizumab in Patients With Advanced Renal Cell Carcinoma: A Sarah Cannon Oncology Research Consortium Phase II Trial ⬇️

artículo científico publicado el 9 de mayo de 2013

Phase I study of JM-216 (an oral platinum analogue) in combination with paclitaxel in patients with advanced malignancies

artículo científico publicado en 2002

Phase I study of paclitaxel and topotecan for the first-line treatment of extensive-stage small cell lung cancer

artículo científico publicado en 2003

Phase I. Trial of irinotecan and temozolomide in patients with solid tumors

artículo científico publicado en 2003

Phase I. Trial of irinotecan plus carboplatin in two dose schedules.

artículo científico publicado en 2003

Phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed/refractory multiple myeloma

artículo científico publicado en 2015

Phase I/II trial of neoadjuvant sunitinib administered with weekly paclitaxel/carboplatin in patients with locally advanced triple-negative breast cancer

artículo científico publicado en 2015

Phase I/II trial of orteronel (TAK-700)--an investigational 17,20-lyase inhibitor--in patients with metastatic castration-resistant prostate cancer

artículo científico publicado en 2014

Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction

artículo científico publicado en 2010

Phase II Study of Neoadjuvant Weekly nab-Paclitaxel and Carboplatin, With Bevacizumab and Trastuzumab, As Treatment For Women With Locally Advanced HER2+ Breast Cancer ⬇️

artículo científico publicado el 5 de mayo de 2011

Phase II multicenter study of arsenic trioxide in patients with myelodysplastic syndromes

artículo científico publicado en 2006

Phase II study of biweekly pemetrexed and gemcitabine in patients with previously untreated advanced non-small cell lung cancer

artículo científico publicado en 2010

Phase II study of capecitabine in combination with thalidomide in patients with metastatic breast cancer

artículo científico publicado en 2010

Phase II study of cetuximab, docetaxel, and gemcitabine in patients with previously untreated advanced non-small-cell lung cancer

artículo científico publicado en 2010

Phase II study of concurrent radiation therapy, temozolomide, and bevacizumab followed by bevacizumab/everolimus as first-line treatment for patients with glioblastoma

artículo científico publicado el 1 de abril de 2012

Phase II study of maintenance sunitinib following irinotecan and carboplatin as first-line treatment for patients with extensive-stage small-cell lung cancer

artículo científico publicado el 3 de mayo de 2012

Phase II study of sunitinib as maintenance therapy in patients with locally advanced or metastatic non-small cell lung cancer ⬇️

artículo científico publicado el 15 de junio de 2011

Phase II trial of FOLFOX6, bevacizumab, and cetuximab in the first-line treatment of metastatic colorectal cancer

artículo científico publicado el 1 de julio de 2010

Phase II trial of bevacizumab and everolimus in patients with advanced renal cell carcinoma

artículo científico publicado en 2010

Phase II trial of docetaxal plus imatinib mesylate in the treatment of patients with metastatic breast cancer

artículo científico publicado en 2009

Phase II trial of irinotecan, carboplatin, and bevacizumab in the treatment of patients with extensive-stage small-cell lung cancer

artículo científico publicado en 2009

Phase II trial of ixabepilone and carboplatin with or without bevacizumab in patients with previously untreated advanced non-small-cell lung cancer ⬇️

artículo científico publicado el 1 de septiembre de 2012

Phase II trial of preoperative pemetrexed plus carboplatin in patients with stage IB-III nonsquamous non-small cell lung cancer (NSCLC).

artículo científico publicado en 2018

Phase II trial of trastuzumab followed by weekly paclitaxel/carboplatin as first-line treatment for patients with metastatic breast cancer

artículo científico publicado en 2004

Phase II trial of vinflunine in relapsed small cell lung cancer.

artículo científico publicado en 2010

Phase II trial of weekly docetaxel, vinorelbine, and trastuzumab in the first-line treatment of patients with HER2-positive metastatic breast cancer

artículo científico publicado en 2009

Poorly differentiated neoplasms of unknown primary site: diagnostic usefulness of a molecular cancer classifier assay

artículo científico publicado en 2015

Practical aspects of weekly docetaxel administration schedules

artículo científico publicado en 2004

Preoperative therapy with concurrent paclitaxel/carboplatin/infusional 5-FU and radiation therapy in locoregional esophageal cancer: final results of a Minnie Pearl Cancer Research Network phase II trial

artículo científico publicado en 2003

Prolonging remission with rituximab maintenance therapy

artículo científico publicado en 2004

Prospective randomized study of four novel chemotherapy regimens in patients with advanced nonsmall cell lung carcinoma: a minnie pearl cancer research network trial

artículo científico publicado en 2002

Publisher Correction: Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma

artículo científico publicado en 2018

Racial differences in presentation and management of follicular non-Hodgkin lymphoma in the United States: report from the National LymphoCare Study

artículo científico publicado en 2012

Randomized phase 2 trial of pemetrexed, pemetrexed/bevacizumab, and pemetrexed/carboplatin/bevacizumab in patients with stage IIIB/IV non-small cell lung cancer and an Eastern Cooperative Oncology Group performance status of 2.

artículo científico publicado en 2018

Randomized phase II comparison of dose-intense gemcitabine: thirty-minute infusion and fixed dose rate infusion in patients with pancreatic adenocarcinoma

artículo científico publicado en 2003

Randomized, Double-Blind, Placebo-Controlled, Phase II Trial of Sorafenib and Erlotinib or Erlotinib Alone in Previously Treated Advanced Non–Small-Cell Lung Cancer ⬇️

artículo científico publicado el 16 de mayo de 2011

Reply to M.-E. Percival et al and L.B. Saltz

artículo científico publicado en 2013

Rituximab plus short-duration chemotherapy as first-line treatment for follicular non-Hodgkin's lymphoma: a phase II trial of the minnie pearl cancer research network

artículo científico publicado en 2005

Rituximab plus short-duration chemotherapy followed by Yttrium-90 Ibritumomab tiuxetan as first-line treatment for patients with follicular non-Hodgkin lymphoma: a phase II trial of the Sarah Cannon Oncology Research Consortium

artículo científico publicado en 2009

Safety and Efficacy of Sorafenib in Elderly Patients Treated in the North American Advanced Renal Cell Carcinoma Sorafenib Expanded Access Program ⬇️

artículo científico publicado el 20 de agosto de 2010

Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE Study

artículo científico publicado en 2008

Safety and efficacy results of the advanced renal cell carcinoma sorafenib expanded access program in North America

artículo científico

Safety of rituximab in the treatment of B cell malignancies: implications for rheumatoid arthritis

artículo científico publicado en 2003

Single agent vinflunine in the salvage treatment of patients with castration-resistant prostate cancer: a phase II trial of the Sarah Cannon research consortium

artículo científico publicado en 2010

Single-Agent Rituximab as First-Line and Maintenance Treatment for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma: A Phase II Trial of the Minnie Pearl Cancer Research Network ⬇️

artículo científico publicado el 1 de mayo de 2003

Single-agent gefitinib in patients with untreated advanced non-small-cell lung cancer and poor performance status: a Minnie Pearl Cancer Research Network Phase II Trial

artículo científico publicado en 2005

Sorafenib Plus Ixabepilone as First-Line Treatment of Metastatic HER2-Negative Breast Cancer: A Sarah Cannon Research Institute Phase I/II Trial

artículo científico publicado en 2016

Sorafenib and Everolimus in Advanced Clear Cell Renal Carcinoma: A Phase I/II Trial of the SCRI Oncology Research Consortium ⬇️

artículo científico publicado el 24 de abril de 2013

Sorafenib and continued erlotinib or sorafenib alone in patients with advanced non-small cell lung cancer progressing on erlotinib: A randomized phase II study of the Sarah Cannon Research Institute (SCRI).

artículo científico publicado en 2017

Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab

artículo científico publicado en 2005

TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer

artículo científico publicado en 2017

Targeted Therapy for Advanced Solid Tumors on the Basis of Molecular Profiles: Results From MyPathway, an Open-Label, Phase IIa Multiple Basket Study

artículo científico publicado en 2018

The addition of granulocyte-colony stimulating factor shifts the dose limiting toxicity and markedly increases the maximum tolerated dose and activity of the kinesin spindle protein inhibitor SB-743921 in patients with relapsed or refractory lymphom

artículo científico publicado en 2015

The role of weekly docetaxel in the treatment of advanced non-small-cell lung cancer

artículo científico publicado en 2002

Tracheoesophageal fistula formation in patients with lung cancer treated with chemoradiation and bevacizumab.

artículo científico publicado en 2009

Treatment for patients with unknown primary cancer and favorable prognostic factors

artículo científico publicado en 2009

Treatment of advanced renal cell carcinoma with the combination bevacizumab/erlotinib/imatinib: a phase I/II trial

artículo científico publicado en 2007

Treatment of metastatic renal cell carcinoma with a combination of bevacizumab and erlotinib

artículo científico publicado en 2005

Updated interim efficacy analysis and long-term safety of abiraterone acetate in metastatic castration-resistant prostate cancer patients without prior chemotherapy (COU-AA-302).

artículo científico publicado en 2014

Use of a multiplexed immunoassay (PRO Onc assay) to detect HER2 abnormalities in circulating tumor cells of women with HER2-negative metastatic breast cancer: lack of response to HER2-targeted therapy

artículo científico publicado en 2016

Weekly combination chemotherapy with docetaxel and gemcitabine as first-line treatment for elderly patients and patients with poor performance status who have extensive-stage small cell lung carcinoma: a Minnie Pearl Cancer Research Network phase II

artículo científico publicado en 2004

Weekly gemcitabine and trastuzumab in the treatment of patients with HER2-overexpressing metastatic breast cancer

artículo científico publicado en 2009

Weekly paclitaxel, estramustine phosphate, and oral etoposide in the treatment of hormone-refractory prostate carcinoma: results of a Minnie Pearl Cancer Research Network phase II trial

artículo científico publicado en 2003

Weekly treatment with bortezomib for patients with recurrent or refractory multiple myeloma: a phase 2 trial of the Minnie Pearl Cancer Research Network

artículo científico publicado en 2008

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda